Difference between revisions of "Prostate cancer"

Jump to navigation Jump to search
1 byte removed ,  20:29, 24 May 2020
m
vauthors
m (vauthors)
 
Line 242: Line 242:


===Situations where prostate adenocarcinoma may be missed===
===Situations where prostate adenocarcinoma may be missed===
Key reasons for false negative prostate samples<ref>{{cite journal |vauthors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}</ref>:
Key reasons for false negative prostate samples<ref>{{cite journal |authors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}</ref>:
*Tissue artefacts (try levels and/or IHC):
*Tissue artefacts (try levels and/or IHC):
**Crush artefact
**Crush artefact
48,860

edits

Navigation menu